Saturday, August 31, 2013
Sleep Apnea by SleepView
<iframe width="640" height="360" src="http://www.youtube.com/embed/V7w2g47aytY?rel=0 feature=player_detailpage" frameborder="0" allowfullscreen></iframe>
Thursday, August 15, 2013
WHAT IS SLEEPVIEW?
The smallest and lightest home sleep monitor with AASM recommended guidelines. The 8 - channel SleepView is ergonomically designed for patients to perform an easy self sleep test at home.WHY YOUR SLEEP FACILITY SHOULD CONSIDER SLEEPVIEW:
ULTRA-COMPACT
Smallest, lightest, Type III, 8 - channel home sleep monitor following the AASM recommended channel set.EASY TO USE
Ergonomically designed for self-administration of sleep test.IDCHECK™
Verify identity of patients during home sleep study.
See Driver Testing Workflow.SENSOR-CHECK
Sensor check lights to indicate proper sensor connection.VALIDATE STUDY QUALITY
"Smart Check" validates quality of recorded sleep study before SleepView is returned to the lab.
SleepView can perform multi-night studies.-
SCORING + REPORTING SOFTWARE
View and score raw data using full PSG capable software.
Customizable reporting. Easy patient record management. WEB PORTAL OPTION AVAILABLE
SleepView's HIPAA compliant Web Portal option allows seamless, secure access to patient's sleep study data, scoring and interpretation.AASM AND CMS COMPLIANT
Generates established AHI.
Airflow by cannula and thermistor.
CLEVEMED RELEASES UPGRADE TO ITS SLEEPVIEW℠ WEB PORTAL
For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
Cleveland, OH - May 16, 2013 - CleveMed, a leader in home sleep diagnostic technology and clinical services, today, announced the release of an upgrade to its web portal (www.clevemedsleepview.com version 3.0). The web portal and associated SleepView® Monitor offer healthcare providers a convenient and cost-effective alternative for diagnosing sleep apnea at home rather than in a sleep lab setting. Sleep Apnea is the most common type of breathing-related sleep disorder. Home Sleep Testing (HST), which costs roughly one fourth of in-lab testing, is gaining popularity as more and more insurers move to reimburse the procedure, a trend that is expected to continue for many years to come.
CleveMed's technology is being adopted nationwide by many market segments. In addition to offering a patient-friendly HST monitor to sleep labs, which is smaller and lighter than any other portable monitor, the web portal makes HST accessible to other healthcare providers as well. Primary care physicians, dentists, cardiologists, now have the ability to deploy HST from within their own practices, while receiving sleep study diagnosis and treatment recommendations via the web from CleveMed's network of registered technologists and board certified sleep physicians. The upgrade announced today, touts many new features, such as giving practice staff the added flexibility to assign sleep studies to qualified sleep scorers or physicians of their own choosing, which will further strengthen local relationships and enhance continuity of patient care.
"Our overall web portal adoption is seeing double digit growth every month, from a variety of sources including sleep specialists and provider practices," said Sarah Weimer, Director of Sleep Products at CleveMed. "Many healthcare providers want to adopt HST. They see sleep apnea patients all the time and hear of their symptoms before anyone else. These providers frequently request local sleep specialists to provide oversight, which can be easily done with our newest web portal release".
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
CLEVEMED RELEASES UPGRADE TO ITS SLEEPVIEW℠ WEB PORTAL
Cleveland, OH - May 16, 2013 - CleveMed, a leader in home sleep diagnostic technology and clinical services, today, announced the release of an upgrade to its web portal (www.clevemedsleepview.com version 3.0). The web portal and associated SleepView® Monitor offer healthcare providers a convenient and cost-effective alternative for diagnosing sleep apnea at home rather than in a sleep lab setting. Sleep Apnea is the most common type of breathing-related sleep disorder. Home Sleep Testing (HST), which costs roughly one fourth of in-lab testing, is gaining popularity as more and more insurers move to reimburse the procedure, a trend that is expected to continue for many years to come.
CleveMed's technology is being adopted nationwide by many market segments. In addition to offering a patient-friendly HST monitor to sleep labs, which is smaller and lighter than any other portable monitor, the web portal makes HST accessible to other healthcare providers as well. Primary care physicians, dentists, cardiologists, now have the ability to deploy HST from within their own practices, while receiving sleep study diagnosis and treatment recommendations via the web from CleveMed's network of registered technologists and board certified sleep physicians. The upgrade announced today, touts many new features, such as giving practice staff the added flexibility to assign sleep studies to qualified sleep scorers or physicians of their own choosing, which will further strengthen local relationships and enhance continuity of patient care.
"Our overall web portal adoption is seeing double digit growth every month, from a variety of sources including sleep specialists and provider practices," said Sarah Weimer, Director of Sleep Products at CleveMed. "Many healthcare providers want to adopt HST. They see sleep apnea patients all the time and hear of their symptoms before anyone else. These providers frequently request local sleep specialists to provide oversight, which can be easily done with our newest web portal release".
IDcheck™ for verification of patient identity during home sleep testing
For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
CleveMed releases IDcheck™ for verification
Cleveland, OH - July 5, 2013 - CleveMed announces the release of IDcheck to verify the identity of patients during home sleep studies with SleepView®. Home sleep testing with IDcheck meets the requirements of many department of transportation guidelines while providing patients with a lower cost alternative to fulfill required testing. The diagnosis and treatment of sleep apnea is vital for preventing daytime sleepiness in drivers, which is a leading factor in auto accidents.
An estimated 40 million people in the US alone are affected by a sleep disorder, many of whom are undiagnosed. About 30 million Americans have undiagnosed Sleep Apnea. Sleep Apnea is the intermittent failure to breathe while you sleep. Obstructive Sleep Apnea (OSA) is the most common type of Apnea. In this form of the disease, the airway collapses, cutting off air flow to the lungs. As Obstructive Sleep Apnea progresses, it has a cumulative effect. This means that the longer the disease goes untreated, the greater the negative side effects and associated health risks. If sleep apnea remains untreated, other health conditions may emerge or current health problems may worsen, including: high blood pressure, heart disease, stroke and diabetes.
"IDcheck is worn discreetly under the patient's shirt, allowing the patient to fully participate in activities during the day," said Sarah Weimer, Director of sleep products, "this is important for patient acceptance and makes the home sleep test very convenient."
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
CleveMed releases IDcheck™ for verification
of patient identity during home sleep testing
Cleveland, OH - July 5, 2013 - CleveMed announces the release of IDcheck to verify the identity of patients during home sleep studies with SleepView®. Home sleep testing with IDcheck meets the requirements of many department of transportation guidelines while providing patients with a lower cost alternative to fulfill required testing. The diagnosis and treatment of sleep apnea is vital for preventing daytime sleepiness in drivers, which is a leading factor in auto accidents.
An estimated 40 million people in the US alone are affected by a sleep disorder, many of whom are undiagnosed. About 30 million Americans have undiagnosed Sleep Apnea. Sleep Apnea is the intermittent failure to breathe while you sleep. Obstructive Sleep Apnea (OSA) is the most common type of Apnea. In this form of the disease, the airway collapses, cutting off air flow to the lungs. As Obstructive Sleep Apnea progresses, it has a cumulative effect. This means that the longer the disease goes untreated, the greater the negative side effects and associated health risks. If sleep apnea remains untreated, other health conditions may emerge or current health problems may worsen, including: high blood pressure, heart disease, stroke and diabetes.
"IDcheck is worn discreetly under the patient's shirt, allowing the patient to fully participate in activities during the day," said Sarah Weimer, Director of sleep products, "this is important for patient acceptance and makes the home sleep test very convenient."
Subscribe to:
Comments (Atom)



.png)